Carotid Artery Disease

Carotid artery disease is atherosclerotic narrowing of the extracranial carotid arteries — most often at the carotid bifurcation / proximal internal carotid artery (ICA) — and is a leading cause of ischaemic stroke. For NEET PG it sits at the intersection of vascular surgery and neurology: expect questions on duplex criteria, NASCET measurement, the symptomatic-vs-asymptomatic stenosis cut-offs for carotid endarterectomy (CEA), and the odd-one-out lesion, the carotid body tumour (chemodectoma).

Definition & classification

Carotid artery disease = atherosclerotic plaque at the carotid bifurcation producing luminal stenosis, plaque ulceration, or a source of artery-to-artery thromboembolism to the brain and retina. The commonest site is the origin of the internal carotid artery just beyond the bifurcation, where turbulent flow and low wall shear stress favour plaque deposition.

Classification is by symptom status and by degree of stenosis, because both drive management:

Axis	Categories	Why it matters
Symptom status	Symptomatic (TIA, stroke, amaurosis fugax in last 6 months on the ipsilateral side) vs Asymptomatic	Symptomatic carries far higher recurrent-stroke risk; lower threshold to intervene
Degree of stenosis	Mild <50%, Moderate 50–69%, Severe 70–99%, Near-occlusion / string sign, Total occlusion	Surgery benefits concentrated in 70–99% symptomatic

High-yield: "Symptomatic" means the carotid lesion has caused an ipsilateral TIA, ischaemic stroke, or transient monocular blindness within the preceding 6 months. Posterior-circulation or contralateral events do NOT make a carotid lesion symptomatic.

Etiology & risk factors

• Atherosclerosis is the dominant cause (>90%). Same risk factors as coronary disease: hypertension, diabetes, smoking, hyperlipidaemia, age, male sex.
• Less common causes: fibromuscular dysplasia (classic "string-of-beads", young women, mid/distal ICA), carotid dissection (young patients, neck trauma/chiropractic manipulation, Horner syndrome + neck pain + cerebral ischaemia), Takayasu arteritis (young Asian women, aortic-arch vessels), radiation-induced arteritis, and moyamoya.

High-yield: Smoking is the single most modifiable risk factor for carotid disease; cessation plus statin + antiplatelet is mandatory regardless of whether surgery is done.

Pathophysiology — how the brain is injured

Two mechanisms, with embolism dominating:

1. Artery-to-artery thromboembolism — fibrin–platelet emboli or cholesterol/atheromatous debris break off an ulcerated plaque and lodge in the middle cerebral artery territory or the central retinal artery. Hollenhorst plaques (bright refractile cholesterol emboli at retinal arteriolar bifurcations) are the fundoscopic clue.
2. Haemodynamic (low-flow) ischaemia — only when stenosis is critical (>90%) and collateral circulation (circle of Willis) is inadequate; produces watershed/border-zone infarcts.

Plaque instability — intraplaque haemorrhage, lipid-rich necrotic core, thin fibrous cap, ulceration — predicts embolic events more than absolute stenosis percentage. This is why a 70% ulcerated symptomatic plaque is more dangerous than a smooth 80% asymptomatic one.

High-yield: Amaurosis fugax = transient, painless, monocular "curtain coming down" visual loss from a retinal embolus via the ophthalmic artery (first branch of ICA). It is a carotid TIA equivalent and mandates carotid imaging.

Clinical features

• Asymptomatic — often discovered via a carotid bruit on routine exam (note: bruit is neither sensitive nor specific; a very tight stenosis may have NO bruit because flow is so reduced).
• TIA — focal neurological deficit lasting <24 h (usually minutes), fully reversible: contralateral hemiparesis, hemisensory loss, dysphasia (dominant hemisphere).
• Amaurosis fugax — ipsilateral transient monocular blindness.
• Ischaemic stroke — fixed deficit in the MCA/ACA territory.
• Carotid body tumour — painless, slowly enlarging, pulsatile mass at the angle of the jaw (see below).

A useful screening rule:

Risk factors → carotid bruit OR TIA/amaurosis fugax → carotid duplex → if 50–99% & symptomatic, confirm with CTA/MRA → CEA within 2 weeks

Diagnosis & investigation of choice

Carotid duplex ultrasound is the first-line and screening investigation of choice — non-invasive, no radiation/contrast, grades stenosis by peak systolic velocity (PSV) and end-diastolic velocity in the ICA, plus the ICA/CCA ratio.

Degree of ICA stenosis	ICA Peak Systolic Velocity (PSV)	ICA/CCA PSV ratio	ICA End-diastolic velocity
Normal / <50%	< 125 cm/s	< 2.0	< 40 cm/s
50–69%	125–230 cm/s	2.0–4.0	40–100 cm/s
70–99% (severe)	> 230 cm/s	> 4.0	> 100 cm/s
Near-occlusion	Variable / may paradoxically fall	—	—
Total occlusion	No flow signal	—	No flow

High-yield: ICA PSV > 230 cm/s indicates ≥70% stenosis — the classic surgical-threshold velocity to memorise.

Confirmatory/anatomical imaging:

• CT angiography (CTA) or MR angiography (MRA) — confirm duplex, define arch anatomy, distinguish near-occlusion from total occlusion (crucial — a totally occluded ICA should NOT be operated, the "string sign" near-occlusion is borderline).
• Digital subtraction angiography (DSA) — historical gold standard and the basis of the NASCET/ECST measurements, but now reserved for equivocal cases because it carries a ~1% procedural stroke risk.

NASCET vs ECST — how stenosis is measured

Two trials measured % stenosis differently using the same angiogram:

Method	Denominator (normal lumen reference)	Effect
NASCET (North American)	Diameter of normal distal ICA beyond the bulb	Gives a lower % for the same lesion (now the standard)
ECST (European)	Estimated diameter of the carotid bulb at the level of stenosis	Gives a higher %

Approximate conversion: ECST 70% ≈ NASCET 50%; ECST 80% ≈ NASCET 60%; ECST 90% ≈ NASCET 80%.

NASCET % = (1 − minimal residual lumen diameter / normal distal ICA diameter) × 100

High-yield: All current guideline cut-offs (70–99% symptomatic, etc.) use the NASCET method. If asked which measurement is the reference standard today — NASCET.

Management

Best medical therapy (for everyone)

• Antiplatelet — aspirin (or clopidogrel); short-term dual antiplatelet after a TIA/minor stroke.
• High-intensity statin — plaque stabilisation, LDL target aggressively low.
• BP control, glycaemic control, smoking cessation.

Carotid endarterectomy (CEA) — definitive surgery

Removal of the atheromatous plaque from the carotid bifurcation, with patch angioplasty to prevent restenosis. Landmark trials (NASCET, ECST, ACAS, ACST) define the benefit.

Scenario	Stenosis	Recommendation
Symptomatic	70–99% (NASCET)	CEA strongly indicated — greatest absolute risk reduction
Symptomatic	50–69%	CEA beneficial, especially men, age >75, recent event
Symptomatic	<50%	Medical therapy only
Asymptomatic	60–99% (selected, low surgical risk, life expectancy >5 yr)	CEA may be offered if perioperative stroke/death risk <3%
Either	Total occlusion	NO surgery

High-yield: In symptomatic severe (70–99%) stenosis, CEA should be done early — ideally within 2 weeks of the index event, because recurrent-stroke risk is highest in the first days. Do NOT delay.

High-yield: For asymptomatic disease the benefit margin is small, so CEA is only justified if the surgeon's/centre's perioperative stroke + death rate is < 3% (for symptomatic, < 6%).

Carotid artery stenting (CAS)

Balloon angioplasty + stent with an embolic protection device. Reserved for patients unsuitable for CEA:

• High surgical risk (severe cardiac/pulmonary disease)
• Surgically hostile neck — prior CEA (restenosis), prior neck irradiation/radical neck dissection, high lesion (above C2), tracheostomy.

High-yield: CREST trial — overall CEA and CAS were comparable, but CAS had more peri-procedural strokes while CEA had more peri-procedural myocardial infarctions; younger patients (<70) did better with stenting, older patients (>70) did better with endarterectomy.

Perioperative stroke risk & complications of CEA

• Stroke (the feared complication; technical embolisation or post-op thrombosis).
• Cranial nerve injury — most commonly hypoglossal nerve (CN XII) → tongue deviates toward the side of injury; also recurrent/superior laryngeal nerve (hoarseness, loss of high notes — superior laryngeal supplies cricothyroid), marginal mandibular branch of facial (drooping mouth corner), and glossopharyngeal (CN IX) with high dissection.
• Cerebral hyperperfusion syndrome — ipsilateral headache, seizures, intracerebral haemorrhage days after restoring flow to a chronically hypoperfused hemisphere; risk with very tight stenosis + post-op hypertension.
• Wound haematoma — dangerous because it can compress the airway; emergency decompression.
• Restenosis, MI, baroreceptor dysfunction (labile BP).

Carotid body tumour (chemodectoma / paraganglioma)

A separate, favourite NEET PG topic that "bridges" with this subject:

• Arises from chemoreceptor (paraganglion) cells of the carotid body at the bifurcation; a paraganglioma.
• Painless, slowly growing, pulsatile mass at the carotid bifurcation; classically mobile side-to-side but not vertically (Fontaine sign).
• More common at high altitude (chronic hypoxia → carotid body hyperplasia); can be familial (SDH gene mutations), bilateral in familial cases.
• Usually non-functional (only ~1–3% secrete catecholamines).
• Imaging: angiography/CTA shows the pathognomonic "lyre sign" / splaying of the external and internal carotid arteries at the bifurcation; highly vascular, intense tumour blush. Biopsy/FNAC is contraindicated (risk of haemorrhage).
• Shamblin classification grades the relationship to the carotid vessels (I = minimal attachment, II = partially encasing, III = encases vessels — predicts resection difficulty).
• Management: surgical excision (often with pre-operative embolisation); radiotherapy if unresectable.

High-yield: "Lyre sign" (splaying of ICA and ECA) + pulsatile bifurcation mass + high altitude = carotid body tumour. Do not biopsy.

Key differentials

Condition	Distinguishing feature
Carotid body tumour	Pulsatile, lyre sign, splays ICA/ECA, do not biopsy
Carotid artery dissection	Young, neck pain + Horner syndrome + cerebral/retinal ischaemia, "flame-shaped" taper on imaging
Fibromuscular dysplasia	Young women, "string of beads", mid/distal ICA
Takayasu arteritis	Young Asian women, pulseless disease, raised ESR, arch vessels
Branchial cyst / lymph node	Non-pulsatile neck mass
Vertebrobasilar TIA	Vertigo, diplopia, bilateral symptoms — NOT a carotid territory event

Recently asked / exam angle

• Investigation of choice for carotid stenosis = duplex ultrasound; PSV > 230 cm/s = ≥70% stenosis. Frequently tested numeric.
• NASCET vs ECST — which denominator each uses, and that NASCET gives a lower percentage and is the current reference. Recurrent image-based questions show a bifurcation diagram asking you to compute % stenosis.
• Symptomatic 70–99% stenosis → CEA within 2 weeks is the single most repeated management line.
• Most common cranial nerve injured in CEA = hypoglossal (XII), with tongue deviation toward the lesion. Superior laryngeal nerve injury → loss of high-pitched voice (singer's nerve, cricothyroid).
• CREST trial comparisons: CAS → more strokes; CEA → more MI; age cut-off 70 for choosing.
• Carotid body tumour — lyre sign, Fontaine sign (horizontal mobility), high-altitude association, contraindication to biopsy, Shamblin classification.
• Amaurosis fugax / Hollenhorst plaque as a carotid embolic marker.
• Cerebral hyperperfusion syndrome as a post-CEA complication with headache and seizures.

A common single-best-answer trap: a patient with a totally occluded ICA is offered surgery — wrong; CEA/CAS is NOT indicated in complete occlusion (no lumen to revascularise, high reperfusion-haemorrhage risk).

Mnemonic for CEA cranial nerves at risk — "Some Hardy Vascular Surgeons May Goof": Superior laryngeal, Hypoglossal (XII), Vagus, Spinal accessory (rare), Marginal mandibular (facial), Glossopharyngeal (IX).

Mnemonic for stenosis surgical thresholds — "7 for symptoms, 6 if silent": 70% symptomatic, 60% asymptomatic.

Rapid revision

• Commonest site of carotid plaque: origin of internal carotid artery at the bifurcation.
• First-line / screening investigation: carotid duplex ultrasound; PSV > 230 cm/s → ≥70% stenosis.
• NASCET method (normal distal ICA as denominator) is today's reference; gives a lower % than ECST.
• Symptomatic = ipsilateral TIA/stroke/amaurosis fugax within 6 months.
• Symptomatic 70–99% → CEA, ideally within 2 weeks of the event.
• Symptomatic 50–69% → CEA in selected (men, elderly, recent event); <50% → medical only.
• Asymptomatic 60–99% → CEA only if perioperative stroke/death risk < 3% (symptomatic threshold < 6%).
• Total carotid occlusion → no surgery.
• CREST: CAS → more strokes, CEA → more MI; stenting favoured in <70 yr / hostile neck, CEA favoured in >70 yr.
• Hypoglossal nerve (XII) is the most commonly injured nerve in CEA; tongue deviates toward the lesion.
• Cerebral hyperperfusion syndrome = headache + seizures + ICH after revascularising a tight stenosis.
• Amaurosis fugax = transient monocular blindness from retinal embolus (ophthalmic artery); Hollenhorst plaque is the fundoscopic sign.
• Carotid body tumour: pulsatile bifurcation mass, lyre sign (splayed ICA/ECA), Fontaine sign (horizontal mobility), high-altitude link, never biopsy, graded by Shamblin.
• Best medical therapy for all: antiplatelet + high-intensity statin + risk-factor control + smoking cessation.